Review Article
Year: 2023 | Month: March | Volume: 13 | Issue: 3 | Pages: 202-211
DOI: https://doi.org/10.52403/ijhsr.20230320
Technological and Therapeutic Approaches to Type 2 Diabetes Management
Rekha Krishnan1, Rashmi Subramanian2, Raja Selvarajan3
1Consultant Physician and Diabetologist, Sevana Hospital, Pattambi, Palakad, Kerala, India
2Chief Research Scientist, Department of Research and Development, Kaveri Healthcare, Bangalore, Karnataka, India
3Consultant Physician and Diabetologist, Kaveri Healthcare, Bangalore, Karnataka, India
Corresponding Author: Rashmi Subramanian
ABSTRACT
There is an increasing burden of cardiovascular and microvascular complications associated with type 2 diabetes throughout the world. Efforts are made to enhance the quality of life and reduce complications caused by the condition. In this regard, improved glucose control remains a crucial factor. Type 2 diabetics' hyperglycaemia has been managed with important therapeutic advances in recent years. There are several drugs that can be used to control diabetes, including dipeptidylpeptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, and sodium glucose transporter-2 inhibitors. In addition to their antihyperglycaemic properties. There appear to be some specific benefits associated with these two classes in terms of cardiovascular and renal health. Insulin therapy is often necessary in many cases with progressing diabetes due to insulin deficiency and hyperglycaemia. Patients with diabetes, as well as their healthcare professionals, are at an increased risk for developing complications as a result of poor glycaemic control due to fear of hypoglycemia, poor understanding of treatment regimens, and lack of engagement with their treatments as a consequence of their clinical need for insulin therapy and their healthcare professionals' hesitation to intensify treatment with insulin. Various diabetes technologies, including dosing advisors, continuous glucose monitoring systems, insulin pumps, and automated insulin delivery systems, are being developed to make life easier for diabetics. These advances are also providing benefits to those with T2D, who face similar challenges in meeting recommended glycaemic standards. The purpose of this review is to examine new therapeutic agents and advanced technology for managing glucose levels in patients with type 2 diabetes. These technologies should be made available to people with T2D in order to reduce the effects of inadequate disease management in this population.
Key words: type 2 diabetes, T2D, metabolic disorders, Type 2 diabetics' hyperglycaemia.